BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun W, Dong WW, Mao LL, Li WM, Cui JT, Xing R, Lu YY. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma. World J Gastroenterol 2013; 19(19): 2913-2920 [PMID: 23704824 DOI: 10.3748/wjg.v19.i19.2913]
URL: https://www.wjgnet.com/1007-9327/full/v19/i19/2913.htm
Number Citing Articles
1
Yage Luo, Lili Wang, Wenwen Ran, Guangqi Li, Yujing Xiao, Xiaonan Wang, Han Zhao, Xiaoming Xing. Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cellsCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1121-6
2
Catherine W.N. Chiu, Carine Monat, Mélanie Robitaille, Marine Lacomme, Avais M. Daulat, Graham Macleod, Helen McNeill, Michel Cayouette, Stéphane Angers. SAPCD2 Controls Spindle Orientation and Asymmetric Divisions by Negatively Regulating the Gαi-LGN-NuMA Ternary ComplexDevelopmental Cell 2016; 36(1): 50 doi: 10.1016/j.devcel.2015.12.016
3
Xueren Gao, Xixi Wang, Shulong Zhang. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinomaBioscience Reports 2018; 38(6) doi: 10.1042/BSR20181441
4
Benoît Chénais, Marine Cornec, Solenne Dumont, Justine Marchand, Vincent Blanckaert. Transcriptomic Response of Breast Cancer Cells MDA-MB-231 to Docosahexaenoic Acid: Downregulation of Lipid and Cholesterol Metabolism Genes and Upregulation of Genes of the Pro-Apoptotic ER-Stress PathwayInternational Journal of Environmental Research and Public Health 2020; 17(10): 3746 doi: 10.3390/ijerph17103746
5
Xiaodong Jia, Po Niu, Cuncun Xie, Hongjian Liu. Long noncoding RNA PXN‐AS1‐L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2Cancer Medicine 2019; 8(9): 4278 doi: 10.1002/cam4.2227
6
Bowen Zhu, Yanqin Wu, Lizhi Niu, Wang Yao, Miao Xue, Hongyu Wang, Jianyong Yang, Jiaping Li, Wenzhe Fan. Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling PathwayFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.574383